Shivam Tyagi

Shivam Tyagi

Shivam Tyagi is a senior correspondent at Business Standard. He covers equity markets and anything that says stocks, analysts, and brokers. After work, you can find him hooked on cinema or hiking in the mountains.

Email
Twitter
LinkedIn

Shivam Tyagi

Tata Power share price surged 3.5 per cent at Rs 375 a piece on the BSE in Wednesday's intraday trade after Tata Power reported a consolidated net profit of Rs 1,188 crore for the third quarter

Updated On: 05 Feb 2025 | 11:17 AM IST

Divi's Laboratories share price surged 5.36 per cent at Rs 6,205 per share on the BSE in the intraday trade of Tuesday. This came after the pharma company delivered robust third quarter results

Updated On: 04 Feb 2025 | 10:28 PM IST

Stocks to watch on February 4, 2025: Power Grid Corporation reported a Q3 consolidated net profit of Rs 3,860 crore, down from Rs 4,030 crore Y-o-Y

Updated On: 04 Feb 2025 | 8:15 AM IST

The Nifty Metal Index slumped 3.37 intraday on Monday, as heavy selling pressure dragged down key stocks across the sector

Updated On: 03 Feb 2025 | 11:15 AM IST

Budget 2025: Individually, Ambika Cotton Mills popped 9.95 per cent, Welsupn Living rallied 5.19 per cent, Adinath Textiles rose 5.91 per cent, Season textiles jumped 4.42 per cent

Updated On: 01 Feb 2025 | 1:29 PM IST

While Sun Pharma continues to demonstrate strength in its branded and specialty businesses, concerns around US generics, R&D investments, and regulatory hurdles leave brokerages divided on its outlook

Updated On: 01 Feb 2025 | 9:38 AM IST

Stocks to watch on February 1, Budget 2025: Stocks from sectors such as Infrastructure & Construction, Banking & Financial Services experience volatility during the budget announcement

Updated On: 01 Feb 2025 | 8:50 AM IST

Stocks to watch on January 31, 2025: Q3 consolidated net profit for Larsen & Toubro was Rs 3,359 crore, up from Rs 2,947 crore Y-o-Y

Updated On: 31 Jan 2025 | 8:18 AM IST

According to brokerage estimates compiled by Business Standard, Sun Pharma may see its average revenue rise by 9.51 per cent year-on-year (Y-o-Y) to Rs 13,313 crore as against Rs 12,156 crore

Updated On: 30 Jan 2025 | 11:41 PM IST

3i Infotech share price gained 19.98 per cent at Rs 31.46 a piece on the BSE in Thursday's intraday trade after the company posted a turnaround in the bottom-line for the third quarter

Updated On: 30 Jan 2025 | 11:33 AM IST

Stocks to watch on January 30, 2025: Bajaj Finance reported a Q3 net profit of Rs 4,240 crore, up from Rs 3,639 crore Y-o-Y, exceeding estimates of Rs 4,098 crore.

Updated On: 30 Jan 2025 | 7:51 AM IST

Ami Organics share price gained 17.69 per cent at Rs 2215.40 a piece on the BSE in Wednesday's intraday trade after the company delivered a significant rise in revenues and profit for Q3FY25

Updated On: 29 Jan 2025 | 1:14 PM IST

Cipla Q3 results review: The shares of the third largest pharmaceutical firm Cipla rose 2.44 per cent at Rs 1,454.20 a piece on the BSE intraday after the company delivered a solid quarterly earnings

Updated On: 29 Jan 2025 | 10:46 AM IST

Stocks to watch on January 29, 2025: Bajaj Auto's Q3 standalone net profit at Rs 2,108 crore compared to Rs 2,042 crore (Y-o-Y); estimate Rs 2,128 crore

Updated On: 29 Jan 2025 | 8:40 AM IST

Cipla Q3 Preview: India's third largest pharmaceutical company, Cipla, is scheduled to deliver its October-December quarterly earnings for the financial year 2024-25 (Q3FY25) on Tuesday, January 28

Updated On: 28 Jan 2025 | 8:29 PM IST

Stocks to watch on January 27, 2025: Tata Steel reported a Q3 net profit of Rs 29.5 crore, a significant decline from Rs 52.2 crore Y-o-Y

Updated On: 28 Jan 2025 | 7:47 AM IST

Laurus Labs share slipped 15 per cent at Rs 510.60 a piece on the BSE in Monday's intraday trade

Updated On: 27 Jan 2025 | 1:11 PM IST

Stocks to watch on January 27, 2025: Q3 standalone net profit increased to Rs 11,790 crore from Rs 10,270 crore (Y-o-Y), beating estimates of Rs 11,330 crore

Updated On: 27 Jan 2025 | 7:57 AM IST

DRL's Q3 performance was viewed as subdued by some analysts when they adjusted it for one-time grants and incomes that the company received during the quarter

Updated On: 24 Jan 2025 | 10:04 PM IST

Dr Reddy's Laboratories reported its consolidated Q3 results with a 2.5 per cent rise in profit to Rs 1,413.3 crore compared to Rs 1,378.9 crore in the same period last year

Updated On: 24 Jan 2025 | 8:17 AM IST